APASL 2020 Annual Meeting in Bali, Indonesia

Date: March 4-8, 2020 City: Bali, Indonesia President: Dr. Rino Gani Website: http://www.apasl2020.org

Ever since its inception, in August 1978 in Singapore, APASL (Asian Pacific Association for the Study of the Liver) never looks back but stick to its goal towards advancing the science and practice of Hepatology. Today it is one of the leading associations based on investigation and treatment of liver diseases in the world and the largest scientific body that upholds the standards and profession, research and create improved treatment methods for millions of liver patients particularly in the entire Asia Pacific Region. APASL’s main objectives are to promote the latest scientific advancement and education of hepatology science, exchange of information and the development of consensus, encourage the practice of medicine in liver diseases and also coordinate scientific studies between various scientists and clinicians throughout the region.

We hold scientific educational symposia/ conferences developed by leading hepatologists periodically. Our events feature expert speakers presenting the finest data in the most happening topics of liver diseases with high quality scientific technical presentations, followed by varied supporting program. Each of our events intended to meet the growing demands of hepatology as core medical specialty and offers participants the right platform to exchange research, discuss outcomes, and interact with colleagues, focused on liver diseases. Our members include all medical professionals dedicated to hepatology — its research, practice and care. We cover the region from Manchuria in the North, to Australia in the South, to the Pacific Islands in the East and Iran in the West.

Our members are elected on their documented scientific publications. Mentoring, sharing of knowledge and dedication to professional growth and development are among the core values of APASL and its members.

It is a great pleasure for us to invite you to the 29th Asian Pacific for The Study of Liver (APASL) 2020 that will be held that will be held 4th-8th March 2020 in Bali Nusa Dua Convention Center (BNDCC) , Bali, Indonesia. The Conference program covering all aspects of hepatology, for that purpose this would be the perfect moment for all of us to join and share the experience, knowledges and also giving the benefits for the population in Asian Pacific Region.

We are looking forward for welcoming you in Bali.

RINO A. GANI APASL President

---

APASL 2021 Annual Meeting in Thailand

Date: February 2021 City: Bangkok, Thailand President: Dr. Tawesak Tanwandee Website: to be announced.

APASL STC 2019 in Tokyo

---

APASL STC 2019 in Baku

---

---

Dear Colleagues,

Please be informed the Impact Factor of our Official Journal “Hepatology International” is now 4.117!

Now the APASL Guidelines have been published in Hepatology International as follows!!!

APASL Guidelines for HBV -"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update" (Hepatol Int 2016; 10:1–98)

*This APASL Guideline can be downloaded by clicking below.

APASL Guidelines for HCV -”APASL consensus statements and recommendation for hepatitis C prevention, epidemiology, and laboratory testing” (Hepatol Int 2016 10:681–701)

*This APASL Guideline can be downloaded by clicking below.

APASL Guidelines for HCV -”APASL consensus statements and recommendation on treatment of hepatitis C” (Hepatol Int 2016 10:702–726)

*This APASL Guideline can be downloaded by clicking below.

APASL Guidelines for HCC -”Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update” (Hepatol Int 2017; 11: 317-370)

*This APASL Guideline can be downloaded by clicking below.

APASL Guidelines for Acute-on-chronic Liver Failure -”Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014” (Hepatol Int 2014; 8: 453-471)

*This APASL Guideline can be downloaded by clicking below.

APASL Guidelines for Fibrosis -”Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL)” (Hepatol Int 2009; 3: 323-333)

*This APASL Guideline can be downloaded by clicking below.

APASL consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis a 2016 update (Hepatol Int 2017 11:1–30)

*This APASL Guideline can be downloaded by clicking below.

APASL Guidelines for IPH -”Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment” (Hepatol Int 2007; 1: 398-413)

*This APASL Guideline can be downloaded by clicking below.

APASL Guidelines for Variceal Bleeding -”Primary prophylaxis of gastroesophageal variceal bleeding: consensus recommendations of the Asian Pacific Association for the Study of the Liver” (Hepatol Int 2008; 2: 429-439)

*This APASL Guideline can be downloaded by clicking below.

The objective of the fellowship is to foster career development by encouraging the beneficial experience of working in a different clinical or research environment in another country in the Asia-Pacific region. These fellowships provide for advanced training in health and medical research in any country in the Asia-Pacific region and enable fellows to work in a clinical environment or on a research project with nominated advisers. We appreciate your generous contributions and support for these APASL fellowships and look forward to a number of high-quality applications for a 2019 fellowship.

An application form can be downloaded by clicking here: http://apasl.info/applicationform-fellowship.docx Please fill in and send to the APASL secretariat (apasl_secretariat@apasl.info). We are looking forward to receiving your application. There are no restrictions based on nationality. The sponsoring institution with the academic environment to provide adequate support for the proposed project might be suggested by APASL. Application will be reviewed by APASL Committee members. The decisions of the Committee are final and not subject to appeal.